GJB2 and cancer: We have found previously that MErT in cancer involves increased epithelial marker expression (connexin 26/43 and E-cadherin) alongside persistent mesenchymal markers (vimentin and FSP1), revealing that phenotypic switching is not just plastic but often incomplete [43].